The incidence of breast cancer in population of young women from Podkarpackie province in 2002–2011

Abstract

IntroductionBreast cancer (BC) in young women of Podkarpackie province accounts for approximately 11.0% of all diagnosed breast tumors.Aim of the studyAim of the study was to assess the trends in incidence of BC among women younger than 44 from Podkarpackie in the years 2002–2011.Material and methods614 cases of malignant BC and 26 cases of cancer in situ were analyzed. The crude and the standardized incidence ratios were estimated; the percentage of histopathologically confirmed cancer cases and the percentage share of registered malignant breast tumors were calculated. The analysis of incidence in individual counties was also presented, as well as the stages of clinical advancement at diagnosis and the methods of treatment.ResultsThe number of registered cases at 2011 was 73, and it was 37.7% higher as compared to 2002. During the period analyzed, the increase in the crude and the standardized cancer incidence ratios was observed. The percentage share of BC in the examined group increased of 5.4% in 2011. Significant variation in incidence among different counties was observed. The incidence ratios ranged from 65.8 to 93.1/100 000. BC in young women most commonly was diagnosed as locally advanced and over 70% of patients were radically treated.ConclusionsEven though the progress in diagnostics and treatment has been made, BC in young women is diagnosed later than it should be and at considerably advanced stage. It is relevant to propagate the knowledge among women and health professionals to emphasize that BC may affect young women.

Polymorphism of DNA repair genes in breast cancer

“…Almost 16,000 of women in Poland are diagnosed annually with breast cancer; the death toll is greater than 5,000. It is estimated that this annual morbidity may rise up to 20 thousand women in 2020 [1, 2]. Following the latest data of Eurocare-5, a five-year survival is achieved by 71.6% of female patients in Poland vs. 82% of the mean European value.…”

Upregulation of Linc00284 Promotes Lung Cancer Progression by Regulating the miR-205-3p/c-Met Axis

“…Lung cancer (LC) is the leading cause of cancer-associated mortality worldwide (Siegel et al, 2020). Although previous studies have demonstrated that various factors, including smoking (Schwartz and Cote, 2016;Tang et al, 2019), environmental pollution (Radziszewska et al, 2015), and genetic mutations (Sharma et al, 2007), are involved in the pathogenesis of LC, the molecular mechanisms responsible for LC initiation and progression are not yet fully clarified. Long intergenic noncoding RNAs (lncRNAs) have been shown to play important roles in various pathophysiological processes (Yang et al, 2014;Gao et al, 2018;Lei et al, 2019).…”

miRNA in a Multiomic Context for Diagnosis, Treatment Monitoring and Personalized Management of Metastatic Breast Cancer

“…Expressed in figures, for example, in the USA the increase of BC incidence in 25-to 39-year old women was from 1.53/100,000 in 1976 up to 2.90/100,000 in 2009 [6]. Data from Europe also show an increase in the number of new malignant BC cases in women under 45 years of age from 16.6 to 37.7% between the years 2002 and 2011 [9].…”